Skip to main content
Log in

Effects of propranolol on gastric mucosal perfusion and serum gastrin level in cirrhotic patients with portal hypertensive gastropathy

  • Liver: Cirrhosis, Fibrosis, Portal Hypertension, And Transplantation
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Gastric mucosal hyperemia associated with elevated serum gastrin level has been suggested in cirrhotic patients with portal hypertensive gastropathy (PHG). Clinical evidence has shown that these patients may benefit from propranolol administration. The aim of this study was to investigate effect of propranolol on gastric mucosal perfusion and serum gastrin level in cirrhotic patients with portal hypertensive gastropathy. Gastric mucosal perfusion was assessed by laser Doppler flowmetry. Measurements were performed under basal conditions and after observer-blind administration of propranolol (30–60 mg/day,N=9) or placebo (N=9) for seven days. Placebo had no effect on either gastric mucosal perfusion or serum gastrin level. In contrast, propranolol administration significantly decreased both antrum gastric mucosal perfusion (from 0.88±0.28 to 0.73±0.26 V,P<0.05) and corpus gastric mucosal perfusion (from 0.94±0.35 to 0.78±0.25 V,P<0.05). However, this drug had no effect on serum gastrin level. We conclude that chronic propranolol administration in cirrhotic patients with portal hypertensive gastropathy may reduce gastric mucosal perfusion without changing serum gastrin level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. D'Amico G, Montalbano L, Traina M, Pisa R, Menozzi M, Spanò C, Pagliaro L, Liver Study Group of V. Cervello Hospital: Natural history of congestive gastropathy in cirrhosis. Gastroenterology 99:1558–1564, 1990

    Google Scholar 

  2. McCormack TT, Sims J, Eyre-Brook I, Kennedy H, Goepel J, Johnson AG, Triger DR: Gastric lesions in portal hypertension: Inflammatory gastritis or congestive gastropathy? Gut 26:1226–1232, 1985

    Google Scholar 

  3. Iwao T, Toyonaga A, Tanikawa K: Gastric red spots in patients with cirrhosis: Subclinical condition of gastric mucosal hemorrhage? Gastroenterol Jpn 25:685–692, 1990

    Google Scholar 

  4. Quintero E, Pique JM, Bombi JA, Bordas JM, Sentis J, Elena M, Bosch J, Rodes J: Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology 93:1054–1061, 1987

    Google Scholar 

  5. Sarfeh IJ, Tarnawski A: Gastric mucosal vasculopathy in portal hypertension. Gastroenterology 93:1129–1131, 1987 (editorial)

    Google Scholar 

  6. Iwao T, Toyonaga A, Sumino M, Takagi K, Oho K, Nishizono M, Ohkubo K, Inoue R, Sasaki E, Tanikawa K: Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology 102:2060–2065, 1992

    Google Scholar 

  7. Iwao T, Toyonaga A, Ikegami M, Sumino M, Oho K, Shigemori H, Sakaki M, Nakayama M, Tanikawa K, Iwao J: Portal vein hemodynamics in cirrhotic patients with portal hypertensive gastropathy: An echo-Doppler study. Hepatogastroenterology (in press)

  8. Yamamoto Y, Sezai S, Sakurabayashi S, Hirano M, Oka H: Effect of hepatic collateral hemodynamics on gastric mucosal blood flow in patients with liver cirrhosis. Dig Dis Sci 37:1319–1323, 1992

    Google Scholar 

  9. Toyonaga A, Iwao T, Shimotsuura Y, Tanikawa K: Endoscopic, histologic and haemodynamic studies on portal hypertensive gastric mucosa. J Gastroenterol Hepatol 4(Suppl 1):132–135, 1989

    Google Scholar 

  10. Iwao T, Toyonaga A, Ikegami M, Oho K, Sumino M, Harada H, Sakaki M, Shigemori H, Aoki T, Tanikawa K: Reduced gastric mucosal blood flow in patients with portal hypertensive gastropathy. Hepatology 18:36–40, 1993

    Google Scholar 

  11. Panés J, Bordas JM, Piqué JM, Bosch J, García-Pagán JC, Feu F, Casadevall M, Terés J, Rodés J: Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology 103:1875–1882, 1992

    Google Scholar 

  12. Guth PH, Smith E: The effect of gastrointestinal hormones on the gastric microcirculation. Gastroenterology 71:435–438, 1976

    Google Scholar 

  13. Hosking SW, Kennedy HJ, Seddon I, Triger DR: The role of propranolol in congestive gastropathy of portal hypertension. Hepatology 7:437–441, 1987

    Google Scholar 

  14. Pérez-Ayuso RM, Piqué JM, Bosch J, Panés J, González A, Pérez R, Rigau J, Quintero E, Valderrama R, Viver J, Esteban R, Rodrigo L, Bordas JM, Rodés J: Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 337:1431–1434, 1991

    Google Scholar 

  15. Panés J, Bordas JM, Piqué JM, García-Pagán JC, Feu F, Terés J, Bosch J, Rodés J: Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Hepatology 17:213–218, 1993

    Google Scholar 

  16. Pugh RNH, Murray-Lyron IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649, 1973

    Google Scholar 

  17. Lunde OC, Kvernebo K, Larsen S: Evaluation of endoscopic laser Doppler flowmetry for measurement of human gastric blood flow. Methodologic aspects. Scand J Gastroenterol 23:1072–1078, 1988

    Google Scholar 

  18. Christoforidis EC, Hovendal C, Bjerring P, Kruse A: Continuous measurement of gastric blood flow by laser-Doppler flowmetry during gastroscopy. Scand J Gastroenterol 24:16–20, 1989

    Google Scholar 

  19. Iwao T, Toyonaga A, Ikegami M, Oho K, Sumino M, Sakaki M, Shigemori H, Harada H, Sasaki E, Tanikawa K: Gastric mucosal blood flow after smoking in healthy human beings assessed by laser Doppler flowmetry. Gastrointest Endosc 39:400–403, 1993

    Google Scholar 

  20. Bonner R, Nossal R: Model for laser Doppler measurements of blood flow in tissue. Appl Opt 20:2097–2107, 1981

    Google Scholar 

  21. Johansson K, Ahn H, Lindhagen J, Lundgren O: Tissue penetration and measuring depth of laser Doppler flowmetry in the gastrointestinal application. Scand J Gastroenterol 22:1081–1088, 1987

    Google Scholar 

  22. Holm L, Perry MA: Role of blood flow in gastric acid secretion. Am J Physiol 254:G281-G293, 1988

    Google Scholar 

  23. Yalow RS, Berson SA: Radioimmunoassay of gastrin. Gastroenterology 58:1–14, 1970

    Google Scholar 

  24. Samloff IM, Liebman WM: Radioimmunoassay of group I pepsinogens in serum. Gastroenterology 66:494–502, 1974

    Google Scholar 

  25. Granger DN, Kvietys PR: Recent advances in measurement of gastrointestinal blood flow. Gastroenterology 88:1073–1076, 1985 (editorial)

    Google Scholar 

  26. Iwao T, Toyonaga A, Ikegami M, Oho K, Sumino M, Sakaki M, Harada H, Tanikawa K: Observer agreement and variability in measuring gastric mucosal blood flow by laser Doppler flowmetry in humans. Endoscopy 25:274–277, 1993

    Google Scholar 

  27. Holm-Rutili L, Berglindh T: Pentagastrin and gastric mucosal blood flow. Am J Physiol 250:G575-G580, 1986

    Google Scholar 

  28. Almond NE, Wheatley AM: Measurement of hepatic perfusion in rats by laser Doppler flowmetry. Am J Physiol 262:G203-G209, 1992

    Google Scholar 

  29. Bosch J, Masti R, Kravetz D, Bruix J, Gaya J, Rigau J, Rodes J: Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology 4:1200–1205, 1984

    Google Scholar 

  30. Rodriguez-Perez F, Groszmann RJ: Pharmacologic treatment of portal hypertension. Gastroenterol Clin N Am 21:15–40, 1992

    Google Scholar 

  31. Sabba C, Ferraioli G, Buonamico P, Berardi E, Antonica G, Taylor KJW, Albano O: Echo-Doppler evaluation of acute flow changes in portal hypertensive patients: Flow velocity as a reliable parameter. J Hepatol 15:356–360, 1992

    Google Scholar 

  32. Zoli M, Marchesini G, Brunori A, Cordiani MR, Pisi E: Portal venous flow in response to acute β-blocker and vasodilatatory treatment in patients with liver cirrhosis. Hepatology 6:1248–1251, 1986

    Google Scholar 

  33. Gaiani S, Bolondi L, Fenyves D, Zironi G, Rigamonti A, Barbara L: Effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Hepatology 14:824–829, 1991

    Google Scholar 

  34. Garcia-Tsao G, Grace ND, Groszmann RJ, Conn HO, Bermann MM, Patrick MJC, Morse SS, Alberts JL: Short-term effects of propranolol on portal venous pressure. Hepatology 6:101–106, 1986

    Google Scholar 

  35. Bendtsen F, Henriksen JH, Sørensen TIA: Propranolol and haemodynamic response in cirrhosis. J Hepatol 13:144–148, 1991

    Google Scholar 

  36. Samloff IM, Secrist DM, Passaro E: A study of the relationship between serum group I pepsinogen levels and gastric acid secretion. Gastroenterology 69:1196–1200, 1975

    Google Scholar 

  37. Pique JM, Pizcueta P, Perez-Ayuso RM, Bosch J: Effects of propranolol on gastric microcirculation and acid secretion in portal hypertensive rats. Hepatology 12:476–480, 1990

    Google Scholar 

  38. Buchan AMJ: Effect of sympathomimetics on gastrin secretion from antral G cells in culture. J Clin Invest 87:1382–1386, 1991

    Google Scholar 

  39. Lebrec D: β-Blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding. Hepato-gastroenterology 37:556–560, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shigemori, H., Iwao, T., Ikegami, M. et al. Effects of propranolol on gastric mucosal perfusion and serum gastrin level in cirrhotic patients with portal hypertensive gastropathy. Digest Dis Sci 39, 2433–2438 (1994). https://doi.org/10.1007/BF02087662

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02087662

Key words

Navigation